国际肿瘤学杂志

国际肿瘤学杂志 ›› 2017, Vol. 44 ›› Issue (2): 115-117.doi: 10.3760/cma.j.issn.1673422X.2017.02.009

• 综述 • 上一篇    下一篇

竞争性内源RNA与肿瘤病理机制

周姝,沈娜,程范军   

  1. 430022 武汉，华中科技大学同济医学院附属协和医院血液科
  • 出版日期:2017-02-08 发布日期:2017-01-04
  • 通讯作者: 程范军,Email: chengfanjun001@sina.com.cn E-mail:chengfanjun001@sina.com.cn

Competing endogenous RNA and tumor pathological mechanism

hou Shu， Shen Na, Cheng Fanjun   

  1. Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
  • Online:2017-02-08 Published:2017-01-04
  • Contact: Cheng Fanjun E-mail:chengfanjun001@sina.com.cn

PDF

1029

被引次数

1

摘要： 竞争性内源RNA（ceRNA）是一类RNA分子的统称，包括mRNA、假基因、长非编码RNA（lncRNA）、环状RNA（circRNA）。ceRNA通过竞争性结合共同的微小RNA（miRNA）而削弱其对mRNA翻译的抑制作用。多项研究已证实ceRNA失调与乳腺癌、胃癌、淋巴瘤等肿瘤发生密切相关。随着ceRNA的研究深入，其或可作为肿瘤的临床诊断标志及治疗靶点。

关键词: 微RNAs, 肿瘤, 基因表达, 竞争性内源RNA

Abstract: Competing endogenous RNA (ceRNA) is a class of RNA which includes mRNA, pseudogenes, long noncoding RNA (lncRNA), circular RNA (circRNA). ceRNA weakens its inhibitory effect on mRNA translation through competitive binding with shared microRNA (miRNA). Many studies have confirmed that the disorder of ceRNA is closely related to the occurrence of breast cancer, gastric cancer, lymphoma and other tumors. With the improvement of researches, ceRNA may be used as a tumor marker of clinical diagnosis and therapeutic target.

Key words: MicroRNAs, Neoplasms, Gene expression, Competing endogenous RNA